135 related articles for article (PubMed ID: 36748322)
1. The association of initiating HPV vaccination at ages 9-10 years and up-to-date status among adolescents ages 13-17 years, 2016-2020.
Minihan AK; Bandi P; Star J; Fisher-Borne M; Saslow D; Jemal A
Hum Vaccin Immunother; 2023 Dec; 19(1):2175555. PubMed ID: 36748322
[TBL] [Abstract][Full Text] [Related]
2. Effect of age at initiation of the human papillomavirus vaccine on the association between race/ethnicity and completion of the vaccine series.
Hirth J; Ostovar-Kermani T; Gutierrez JA; Thompson EL; Barnett TE; Zoorob R
Vaccine; 2024 Apr; 42(11):2827-2836. PubMed ID: 38519345
[TBL] [Abstract][Full Text] [Related]
3. Descriptive epidemiology of age at HPV vaccination: Analysis using the 2020 NIS-Teen.
Bednarczyk RA; Brandt HM
Hum Vaccin Immunother; 2023 Dec; 19(1):2204784. PubMed ID: 37138466
[TBL] [Abstract][Full Text] [Related]
4. Trends in HPV Vaccination Initiation and Completion Within Ages 9-12 Years: 2008-2018.
Chido-Amajuoyi OG; Talluri R; Wonodi C; Shete S
Pediatrics; 2021 Jun; 147(6):. PubMed ID: 33941585
[TBL] [Abstract][Full Text] [Related]
5. County-Level Factors Associated With HPV Vaccine Coverage Among 11-Year-Olds to 12-Year-Olds Living in Florida in 2019.
Osegueda ER; Chi X; Hall JM; Vadaparampil ST; Christy SM; Staras SAS
J Adolesc Health; 2023 Jan; 72(1):130-137. PubMed ID: 36244897
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus vaccinations at recommended ages: How a middle school-based educational and vaccination program increased uptake in the Rio Grande Valley.
Rodriguez AM; Do TQN; Chen L; Schmeler KM; Montealegre JR; Kuo YF
Hum Vaccin Immunother; 2022 Nov; 18(6):2133315. PubMed ID: 36252275
[TBL] [Abstract][Full Text] [Related]
7. Ancillary Benefit of Increased HPV Immunization Rates Following a CBPR Approach to Address Immunization Disparities in Younger Siblings.
Lennon T; Gundacker C; Nugent M; Simpson P; Magallanes NK; West C; Willis E
J Community Health; 2019 Jun; 44(3):544-551. PubMed ID: 30604221
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing Human papillomavirus (HPV) vaccination series completion in Mississippi Medicaid.
Inguva S; Barnard M; Ward LM; Yang Y; Pittman E; Banahan BF; Kirby TR; Noble SL
Vaccine; 2020 Feb; 38(8):2051-2057. PubMed ID: 31980196
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with not receiving HPV vaccine among adolescents by metropolitan statistical area status, United States, National Immunization Survey-Teen, 2016-2017.
Williams CL; Walker TY; Elam-Evans LD; Yankey D; Fredua B; Saraiya M; Stokley S
Hum Vaccin Immunother; 2020 Mar; 16(3):562-572. PubMed ID: 31584312
[TBL] [Abstract][Full Text] [Related]
10. Factors Associated with Increased HPV Vaccine Use in Rural-Frontier U.S. States.
Lai D; Ding Q; Bodson J; Warner EL; Kepka D
Public Health Nurs; 2016 Jul; 33(4):283-94. PubMed ID: 26331614
[TBL] [Abstract][Full Text] [Related]
11. An Evaluation of Dose-Related HPV Vaccine Effectiveness Using Central Registries in Michigan.
Gargano JW; You M; Potter R; Alverson G; Swanson R; Saraiya M; Markowitz LE; Copeland G
Cancer Epidemiol Biomarkers Prev; 2022 Jan; 31(1):183-191. PubMed ID: 34663615
[TBL] [Abstract][Full Text] [Related]
12. Early Initiation of HPV Vaccination and Series Completion in Early and Mid-Adolescence.
Goodman E; Felsher M; Wang D; Yao L; Chen YT
Pediatrics; 2023 Mar; 151(3):. PubMed ID: 36843509
[TBL] [Abstract][Full Text] [Related]
13. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2020.
Pingali C; Yankey D; Elam-Evans LD; Markowitz LE; Williams CL; Fredua B; McNamara LA; Stokley S; Singleton JA
MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(35):1183-1190. PubMed ID: 34473682
[TBL] [Abstract][Full Text] [Related]
14. A Mixed-Methods Analysis of Barriers to and Facilitators of Human Papillomavirus Vaccination Among Adolescents in Montana.
Newcomer SR; Caringi J; Jones B; Coyle E; Schehl T; Daley MF
Public Health Rep; 2020; 135(6):842-850. PubMed ID: 32972304
[TBL] [Abstract][Full Text] [Related]
15. Adolescent Vaccination Performance in South Carolina Compared to the United States.
Roberts JR; Naifeh M; Jacobson RM; Hinton E; O'Brien E; Rogacki B; Thompson D; Margolis B; Darden PM
J S C Med Assoc; 2015 Dec-2016 Jan; 111(4):117-21. PubMed ID: 27141702
[TBL] [Abstract][Full Text] [Related]
16. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017.
Walker TY; Elam-Evans LD; Yankey D; Markowitz LE; Williams CL; Mbaeyi SA; Fredua B; Stokley S
MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(33):909-917. PubMed ID: 30138305
[TBL] [Abstract][Full Text] [Related]
17. Systematic identification and replication of factors associated with human papillomavirus vaccine initiation among adolescents in the United States using an environment-wide association study approach.
Nasserie T; Bendavid E
Sex Transm Infect; 2022 May; 98(3):203-209. PubMed ID: 34039744
[TBL] [Abstract][Full Text] [Related]
18. HPV vaccination initiation after the routine-recommended ages of 11-12 in the United States.
Beachler DC; Gonzales FA; Kobrin SC; Kreimer AR
Papillomavirus Res; 2016 Dec; 2():11-16. PubMed ID: 26783559
[TBL] [Abstract][Full Text] [Related]
19. Regional variation in human papillomavirus vaccination uptake and completion among adolescents 13-17 in the state of Texas.
Conrey R; Valencia V; Cioletti A; Williams-Brown MY
Vaccine; 2020 May; 38(25):4119-4124. PubMed ID: 32349907
[TBL] [Abstract][Full Text] [Related]
20. Reaching 80% human papillomavirus vaccination prevalence by 2026: How many adolescents need to be vaccinated and what are their characteristics?
Fedewa SA; Preiss AJ; Fisher-Borne M; Goding Sauer A; Jemal A; Saslow D
Cancer; 2018 Dec; 124(24):4720-4730. PubMed ID: 30257056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
